Medical management during the period of AAA surveillance. We recommend smoking cessation to reduce the risk of AAA growth and rupture. Level of recommendation: 1 (Strong), Quality of evidence: B (Moderate)

We suggest not administering statins, doxycycline, roxithromycin, ACE inhibitors, or angiotensin receptor blockers for the sole purpose of reducing the risk of AAA expansion and rupture. Level of recommendation: 2 (Weak), Quality of evidence: C (Low)

We suggest not administering beta blocker therapy for the sole purpose of reducing the risk of AAA expansion and rupture. Level of recommendation: 1 (Strong), Quality of evidence: B (Moderate)